Press release
US Diabetes Devices Market Accelerates with Tech-Driven Solutions for Type 1 & Type 2 Diabetes Management | Expected to Reach US$ 18.93 Billion by 2033
US Diabetes Devices Market
Market growth opportunities(2025-2031):
The U.S. diabetes devices market is positioned for steady expansion through 2030, as innovations in personalized care and integrated platforms drive adoption. Expansion of over-the-counter continuous glucose monitors (CGMs) and insulin delivery systems broadens access beyond traditional insulin-dependent users. Interoperable closed-loop systems combining CGMs, pumps, and AI-enhanced algorithms are increasingly available for both type 1 and type 2 patients. Smart, connected devices with mobile app integrations enhance trend-based therapy adjustments and remote patient coaching. Elevated payer coverage and digital health partnerships also underpin robust uptake across diverse patient cohorts.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/us-diabetes-devices-market?sp
US Diabetes Devices Market: Recent Industry Developments
✅ In July 2025, Dexcom launched the G8 Continuous Glucose Monitor (CGM) in the U.S., featuring predictive alerts, faster warm-up times, and Bluetooth 6.0 connectivity. It aims to improve glucose control with greater accuracy and seamless smartphone integration.
✅ In June 2025, Insulet Corporation began full U.S. rollout of its Omnipod 5 Automated Insulin Delivery system for type 2 diabetes. The wearable, tubeless pump uses adaptive algorithms and CGM input to adjust insulin in real-time, supporting easier self-management.
✅ In May 2025, Abbott's FreeStyle Libre 3 received CMS reimbursement expansion, making the CGM available to more Medicare patients with type 2 diabetes not on insulin. This move significantly increases access to real-time glucose data for high-risk populations.
✅ In April 2025, Medtronic secured FDA approval for its MiniMedTM 780G insulin pump, designed with Meal DetectionTM technology and automatic corrections. The device allows users to stay within range even with occasional missed boluses.
✅ In March 2025, Tandem Diabetes Care introduced the t:slim X3 pump platform, featuring advanced cybersecurity, longer battery life, and full interoperability with future CGM systems. It sets the stage for next-gen, personalized insulin delivery.
US Diabetes Devices Market: Drivers
Key drivers include the growing prevalence of diabetes in the U.S., particularly type 2, which is increasing the number of individuals needing daily monitoring and therapy support. Advances in sensor technology and miniaturization have enabled the development of more accurate, comfortable, and user-friendly devices. Regulatory approval of over-the-counter CGMs and automated insulin delivery systems is simplifying patient access. Expanded insurance coverage, including Medicare support for CGMs and insulin caps, is accelerating adoption among older adults and underserved populations. Furthermore, the rise of telehealth and digital health platforms is encouraging the use of remote-monitoring-compatible devices, fostering better adherence and long-term glycemic control.
Strategic Players Driving the US Diabetes Devices Market Forward:
F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Insulet Corporation, Nipro Corporation, Johnson & Johnson Services, Inc., Senseonics, Inc., Tandem Diabetes Care, Inc. and among others.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/us-diabetes-devices-market?sp
Segment Covered in the US Diabetes Devices Market:
➥By Product Type: Blood Glucose Monitoring Devices, Insulin Delivery Devices, Others
➥By End-User: Hospitals, Specialty Clinics, Homecare Settings, Diagnostic Centers, Others
Regional Analysis for US Diabetes Devices Market:
The United States remains the largest and most technologically advanced diabetes devices market globally. It leads in product innovation, clinical adoption, and regulatory support for device-based diabetes care. The market benefits from a strong infrastructure, high awareness, and widespread availability of digital and home-based healthcare services. Increasing investments in digital therapeutics and hybrid care delivery models are reinforcing the U.S. position as a global hub for diabetes device innovation.
Why Purchase the Report for US Diabetes Devices Market?:
➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=us-diabetes-devices-market?sp
Conclusion:
The U.S. diabetes devices market continues to evolve rapidly, with technology-driven innovation and personalized care at its core. The integration of AI, real-time monitoring, and connected platforms is improving both patient experience and treatment outcomes. Growth is supported by a favorable policy landscape, increasing consumer demand for self-care solutions, and a shift toward preventive, data-driven diabetes management. Companies that focus on accessibility, simplicity, and interoperability will be best positioned to succeed in this dynamic market.
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Diabetes Devices Market Accelerates with Tech-Driven Solutions for Type 1 & Type 2 Diabetes Management | Expected to Reach US$ 18.93 Billion by 2033 here
News-ID: 4131122 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Automated Hematology Analyzer Market Growth 2025-2033
The Global Automated Hematology Analyzer Market grew from US$468.72 million in 2023 to US$504.00 million in 2024 and is projected to reach US$960.51 million by 2033, registering a CAGR of 8.4%
The Automated Hematology Analyzer Market involves systems that automatically analyze blood samples to measure cell counts, hemoglobin, and platelets, ensuring fast and accurate diagnostics. It includes 3-part and 5-part differential analyzers widely used in hospitals, labs, and research centers for…
United States Digital Commerce Software Market 2025 | Growth Drivers, Market For …
Market Size and Growth
The Digital Commerce Software Market is predicted to reach at a Significant CAGR during the forecast period (2024-2031)
Key Development:
United States: Digital Commerce Software Developments
✅ October 2025: Shopify launched the "AI Store Builder," enabling merchants to create fully functional online stores using descriptive keywords. This tool generates complete store layouts, including images and text, streamlining the setup process and minimizing the time and resources needed.
✅ October 2025: OpenAI…
United States Agricultural Microbial Market 2025 | Growth Drivers, Key Players & …
Market Size and Growth
The Global "Agricultural Microbial Market" is expected to grow at a high CAGR during the forecasting period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In September 2025, the agricultural microbials market in the U.S. was projected to surpass $11 billion, driven by sustainable farming innovations and increased adoption of microbial products to reduce chemical usage.
✅ In June 2025, Bayer and Kimitec launched Ambition Complete Gen2 and Secure Gen2,…
Alopecia Areata Market Size to Reach $6.20 Billion by 2033 | Growth Driven by JA …
DataM Intelligence announces the publication of its detailed report, "Alopecia Areata Market: Size, Share, Trends & Forecast 2025-2033." According to the latest analysis, the global Alopecia Areata market was valued at approximately USD 3.25 billion in 2024 and is expected to grow at a CAGR of ~7.5%, reaching about USD 6.20 billion by 2033. The year 2025 is already showing accelerated momentum, driven by newly approved therapies, growing awareness of…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
